Cellulite Treatment Market
Market Insights on Cellulite Treatment covering sales outlook, demand forecast & up-to-date key trends
Cellulite Treatment Market by Treatment Procedure, Cellulite, End User & Region - Forecast to 2022-2028
Cellulite Treatment Market Outlook (2022-2028)
[272 Pages Report] Global demand for cellulite treatment is predicted to expand at an impressive CAGR of 7.8% to US$ 5.2 Bn in 2028, supported by:
- Physical appearance, growing urbanization, unhealthy eating habits, an aging population, a rise in the prevalence of obesity, constant medication use, and so on.
- The growth in popularity of social media and celebrities' rising impact on the wider populace.
- Increased cosmetic procedure penetration significantly in recent years.
The global COVID-19 pandemic had a substantial impact on all markets and businesses, including the aesthetic market. Lockdowns imposed in nearly every country had a devastating effect on the global economy. The COVID-19 pandemic also had repercussions on the cellulite treatment market.
The burgeoning obese population, caused by poor dietary habits and inactivity, may drive the cellulite treatment market forward in the coming years. According to the WHO, in 2020, approximately 39 million children under the age of five were obese or overweight. Boosting aesthetic appeal and fitness awareness among youth, leading to an increase in consumption of cosmetic procedures, could compel the industry to forecast over the forecast timeframe. New product innovations driven by increased R&D activities will all contribute to market growth. For example, the FDA recently approved Soliton's Rapid Acoustic Pulse device, which guarantees short-term advancement in cellulite appearance.
|
Global Cellulite Treatment Market Size (2022) |
US$ 3.3 Bn |
|
Revenue Forecast (2028) |
US$ 5.2 Bn |
|
Global Market Growth Rate (2022-2028) |
7.8% CAGR |
|
North America Market Share |
40% |
Let us know your requirement to get
100% FREE customization
North America is lucratively leading the Anti-Cellulite Treatment Landscape
In 2022, the North American cellulite treatment market is anticipated to account for approximately 40% of the global market. The region's soaring obesity prevalence and growing geriatric population are key factors shaping this regional market.
The aesthetic appeal industry in the United States has developed dramatically over the last decade, owing primarily to the growing popularity of social media in the country. Celebrities and social influencers' escalating need for the perfect figure and perfect life standards have significantly contributed to changes in aesthetic trends and molded the anti-cellulite treatment industry in the United States and around the world.
Some of the main determinants predicted to guide the cellulite treatment industry are the availability of a wide range of skin treatment and aesthetic treatments, the increasing purchasing potential of the population, the rising influence of anti-cellulite massage procedures, and the presence of major cellulite treatment providers. Obesity is also predicted to affect the adoption of cellulite treatment, anti-cellulite massage procedures, and other cosmetic procedures in the North American population.
Opportunities abound in the Non-Invasive Cellulite Treatment Segment
With a market revenue of more than 35.0% in 2021, the non-invasive segment dominated the market. The non-invasive segment is predicted to expand significantly over the forecast period. This can be contributed to the procedure's high reliability as well as enduring R&D activities. In regards to market share, the topical segment trailed the non-invasive segment.
Topical cellulite treatment products do not require the application of a medical specialist and can be employed in the comfort of an individual's home, bolstering the market growth. The potential side effects of topical agents, on the other hand, are expected to inhibit segment growth.
Noninvasive operations, such as the utilization of radiofrequency waves, are the favored treatment option since they induce no skin damage and generate effective results. The ease of obtaining topical treatments in various healthcare settings and over-the-counter creams for cellulite treatment is increasing their use at home.
Cellulite treatment accounts for 32.5% share of the global aesthetics at present. Increasing demand to look aesthetically perfect due to beauty standards set by celebrities and influencers is expected to shape cellulite treatment demand over the years to come.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystHow The Market Progressed Till June 2022?
|
Particulars |
Details |
|
H1, 2021 |
7.71% |
|
H1, 2022 Projected |
7.77% |
|
H1, 2022 Outlook |
7.67% |
|
BPS Change - H1, 2022 (O) – H1, 2022 (P) |
(-) 10 ↓ |
|
BPS Change – H1, 2022 (O) – H1, 2021 |
(-) 04 ↓ |
The global cellulite treatment market is subject to product adoption rates, regulatory scenario, product induction in low income economies, and the emergence of cosmetic procedures for aesthetical outlook.
According to Future Market Insights analysis, the global cellulite treatment market expects to drop by 04 Basis Point Share (BPS) in H1-2022 as compared to H1- 2021. Whereas in comparison to H1-2022 Projected value, the market during H1-2022 outlook period will show a dip of 10 BPS.
The key developments in the market include laser assisted liposuction which is a minimally invasive laser treatment, non-invasive laser treatment, and non-invasive cryo, and carboxytherapy which includes non-invasive CO2 injections. The market is highly influenced by emergence of topical anti-cellulite creams, and the emergence of radiofrequency therapy for cellulite reduction.
The market decline observed through the drop in the BPS values is addressed by the reduction in the rate of adoption of cosmetic procedures, owed to global restrictions in travelling and public gatherings with the COVID-19 pandemic advent.
Moreover, the medical tourism market faced a significant reduction in the in-flow of foreign patients into regions with cosmetic and aesthetic surgical procedure hubs at lowered costs, thus further restraining the market outlook for cellulite treatment.
Cellulite Treatment Demand Analysis (2013 to 2021) Vs Market Outlook (2022 to 2028)
“Popularity of Cellulite Removal Procedures to Increase Going Ahead”
Physical appearance has become one of the most important parts of personality and maintaining a perfect image is one of the foremost trends in these modern times. Changing lifestyles, unhealthy eating habits, rising geriatric population, increasing prevalence of obesity, constant intake of medications, etc., are some of the major factors influencing demand growth for cellulite treatment on a global scale.
The cellulite treatment market rose at a CAGR of 6.8% from 2013 to 2021 and amassed revenue worth US$ 3.1 Bn in 2021. Penetration of cosmetic procedures has substantially increased over the past few years, and this has aided the cellulite treatment industry in the long run.
Moreover, rising popularity of social media and increasing influence of celebrities on the general population are also expected to promote demand for cellulite treatment procedures on a global level.
Cellulite removal treatment demand is predicted to progress at a high CAGR of 7.8% from 2022 to 2028. The cellulite treatment market is expected to recover from its slump in the COVID-19 pandemic and rise at the predicted growth rate to end up with an estimated net worth of US$ 5.2 Bn by 2028.
A unified Market Research Subscription Platform, built for today's disparate research needs.
Which Regional Markets are Set to Be Lucrative for Cellulite Treatment Vendors?
“North America Handsomely Leading Anti-cellulite Treatment Landscape”
These cellulite treatment market insights shed light on the metrics for regions such as North America, Latin America, Europe, East Asia, South Asia & Pacific, and the Middle East & Africa (MEA).
The North American cellulite treatment market is expected to account for the highest market share of around 40% in the global landscape in 2022. Rising prevalence of obesity and increasing geriatric population in the region are majorly responsible for shaping this regional market.
The cellulite treatment markets in Western Europe and Eastern Europe are expected to be driven by rising popularity of cellulite treatment procedures, increasing medical research and development, etc. Market potential is also predicted to be driven by increasing spending potential of the population in these regions over the forecast period.
The Latin American anti-cellulite treatment market will account for 6.6% of the global market share in 2022. Demand for cellulite treatment products in this region is expected to be majorly driven by emerging economies such as Brazil. Demand for anti-cellulite massage options is also expected to rise as emphasis on aesthetic appearance and skin care increases over the coming years.
The cellulite treatment markets in East Asia, South Asia, and the Pacific regions are anticipated to be crucially driven by factors such as cheaper treatment costs, rising emphasis on aesthetic appearance, increasing disposable income, and prevalence of obesity. Crucially, China, Japan, and India are expected to spearhead cellulite treatment demand in these regions.
The cellulite treatment market in the MEA region is expected to progress at a slightly slower rate than other regions, but this trend is anticipated to change by the end of the forecast period. In 2022, the market in MEA is set to account for 4.1% of the global market share.
Country-wise Analysis
What is the Outlook for Cellulite Treatment in China?
“Low Cost of Cellulite Removal Procedures Complementing Regional Market Expansion”
The Chinese market currently accounts for nearly 8% of the global cellulite treatment industry. Demand for cellulite removal in the nation is expected to rise at a healthy CAGR over the forecast period, and this can be attributed to cheaper treatment prices, increasing popularity of cellulite treatments, rising aesthetic awareness among the general population, increasing disposable income, growing popularity of skin care treatments, etc.
How is Demand for Cellulite Treatment Expected to Shape Up in the U.S.?
“Anti-cellulite Massage Hugely Popular in the Country”
The U.S. has seen a sharp rise in its aesthetics industry over the past decade, and this can majorly be attributed to the increased popularity of social media in the nation. Increasing need for the perfect body and perfect life standards set by celebrities and social influencers has majorly contributed to change in the aesthetic trends and shaped the anti-cellulite treatment industry in the U.S. as well as the rest of the world.
Availability of a wide array of skin treatment and aesthetic treatments, rising spending potential of the population, growing popularity of anti-cellulite massage procedures, and presence of major cellulite treatment providers are some of the major factors predicted to guide the cellulite treatment industry. Widespread prevalence of obesity is also expected to shape the adoption of cellulite treatment, anti-cellulite massage procedures, and other cosmetic procedures among the U.S. population.
Category-wise Analysis
Which Cellulite Treatment Procedure is Set to Gain Immense Popularity?
“High Effectiveness of Non-invasive Cellulite Removal Procedures Driving Segment Growth”
Non-invasive medical procedures have gained quite a lot of popularity over the past few years, and this trend has also been quite prevalent in the cellulite treatment market. Non-invasive cellulite treatment procedures are preferred over other cosmetic procedures due to their advantages and effectiveness.
Non-invasive cellulite treatment is expected to expand at an estimated high CAGR of around 8% over the forecast period, and is expected to maintain its stance as the dominant segment in the body contouring treatment space over the coming years as well.
COVID-19 Impact on Market
The pandemic of 2020 negatively impacted almost all medical procedures over 2020 and 2021. COVID-19 pandemic restrictions didn’t allow people to visit hospitals for different medical treatments and procedures. The same drop was experienced by the cellulite treatment market as well. Supply chain disruptions led to the shortage of equipment and essential drugs or materials required to perform successful cellulite removal procedures.
However, the pandemic helped boost sales of at-home cellulite treatment. This is expected to change over the post-pandemic era as activities return to normalcy and cellulite treatments gain popularity. The market is expected to return to its full potential by the end of 2022 and progress throughout the forecast period as skin treatment and body treatment procedures gain importance across regions.
Competitive Landscape
Cellulite treatment companies are focusing on deploying organic and inorganic growth strategies to promote their products across multiple geographies. Body contouring treatment providers are also focusing on mergers and collaborations to expand their market presence across the world.
- In April 2021, the U.S. Food and Drug Administration (FDA) approved the use of the first injectable treatment for cellulite in the buttocks. The new injectable enzyme treatment is called Qwo, and has been made available in doctors’ offices as well.
- In 2021, a new technology for cellulite treatment was launched and became a hit instantly. The technology, called Resonic, is a non-invasive cellulite treatment procedure that aims to reduce cellulite in just one session of an hour.
Cellulite Treatment Industry Report Scope
|
Attribute |
Details |
|
Forecast Period |
2022-2028 |
|
Historical Data Available for |
2013-2021 |
|
Market Analysis |
US$ Mn for Value |
|
Key Regions Covered |
|
|
Key Countries Covered |
|
|
Key Market Segments Covered |
|
|
Key Companies Profiled |
|
|
Pricing |
Available upon Request |
Key Segments of Cellulite Treatment Market Survey
Cellulite Treatment Market by Treatment Procedure:
- Non-Invasive Cellulite Treatment
- Minimally Invasive Cellulite Treatment
- Topical Cellulite Treatment
Cellulite Treatment Market by Cellulite:
- Soft Cellulite
- Hard Cellulite
- Edematous Cellulite
Cellulite Treatment Market by End User:
- Cellulite Treatment in Hospitals
- Cellulite Treatment in Ambulatory Surgical Centres
- Cellulite Treatment in Specialized Dermatology Clinics
Cellulite Treatment Market by Region:
- North America Cellulite Treatment Market
- Latin America Cellulite Treatment Market
- Europe Cellulite Treatment Market
- East Asia Cellulite Treatment Market
- South Asia & Pacific Cellulite Treatment Market
- Middle East & Africa (MEA) Cellulite Treatment Market
Frequently Asked Questions
At what pace is the cellulite treatment market expected to increase over the coming years?
The global cellulite treatment market is estimated to surge at a CAGR of 7.8% through 2028.
At present, what valuation does the cellulite treatment market enjoy?
The global market for cellulite treatment devices and procedures is currently worth US$ 3.3 Bn.
Which prime cellulite treatment market players are profiled in this analysis?
Key skin care players such as Tanceuticals LLC, Inceler Medikal Co. Ltd., Cymedics, Nubway, Zimmer Aesthetics, Syneron Medical Inc., etc., are profiled in this cellulite treatment market survey.
What is the cellulite treatment market predicted to be worth by 2028?
In 2028, cellulite treatment procedure demand is anticipated to attain a valuation of US$ 5.2 Bn.
What market share is held by Japan?
The Japan cellulite treatment market currently holds 6.2% share in the global market.
Table of Content
1. Executive Summary 1.1. Market Overview 1.2. Market Analysis 1.3. FMI Analysis and Recommendations 1.4. Wheel of Fortune 2. Market Introduction 2.1. Market Taxonomy 2.2. Market Definition 3. Market Opportunity Analysis 3.1. Macro-Economic Factors 3.2. Opportunity Analysis 4. Global Economic Outlook 4.1. Global Gross Domestic Product by Region & Country 5. Market Background 5.1. Market Dynamics 5.1.1. Drivers 5.1.2. Restraints 5.2. Therapeutic Area 5.3. Regulatory Scenario 6. Global Economic Outlook 6.1. Gross Domestic Product by Region & Country, 2006 – 2021 7. Key Inclusions 7.1. Total Cosmetic Surgical Procedures 7.2. Value Chain 8. North America Market Analysis 2013-2021 and Forecast 2022-2028 8.1. Introduction 8.2. Historical Market Size (US$ Mn) Analysis By Country, 2013-2021 8.2.1. U.S. 8.2.2. Canada 8.3. Market Size (US$ Mn) Forecast By Country, 2022-2028 8.3.1. U.S. 8.3.2. Canada 8.4. Historical Market Size (US$ Mn) Trend Analysis By Treatment Procedure, 2013-2021 8.4.1. Non-Invasive 8.4.2. Minimally Invasive 8.4.3. Topical Treatment 8.5. Market Size (US$ Mn) Forecast By Treatment Procedure, 2022-2028 8.6. Historical Market Size (US$ Mn) Trend Analysis By Cellulite, 2013-2021 8.6.1. Soft Cellulite 8.6.2. Hard Cellulite 8.6.3. Edematous Cellulite 8.7. Market Size (US$ Mn) Forecast By Cellulite, 2022-2028 8.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021 8.8.1. Hospitals 8.8.2. Ambulatory Surgical Centers 8.8.3. Specialized Dermatology Clinics 8.9. Market Size (US$ Mn) Forecast By End User, 2022-2028 8.10. Drivers and Restraints: Impact Analysis 8.11. Market Attractiveness Analysis 8.11.1. By Country 8.11.2. By Treatment Procedure 8.11.3. By Cellulite 8.11.4. By End User 8.12. Key Market Participants – Intensity Mapping 9. Latin America Market Analysis 2013-2021 and Forecast 2022-2028 9.1. Introduction 9.2. Historical Market Size (US$ Mn) Analysis By Country, 2013-2021 9.2.1. Brazil 9.2.2. Mexico 9.2.3. Rest of Latin America 9.3. Market Size (US$ Mn) Forecast By Country, 2022-2028 9.3.1. Brazil 9.3.2. Mexico 9.3.3. Rest of Latin America 9.4. Historical Market Size (US$ Mn) Trend Analysis By Treatment Procedure, 2013-2021 9.4.1. Non-Invasive 9.4.2. Minimally Invasive 9.4.3. Topical Treatment 9.5. Market Size (US$ Mn) Forecast By Treatment Procedure, 2022-2028 9.6. Historical Market Size (US$ Mn) Trend Analysis By Cellulite, 2013-2021 9.6.1. Soft Cellulite 9.6.2. Hard Cellulite 9.6.3. Edematous Cellulite 9.7. Market Size (US$ Mn) Forecast By Cellulite, 2022-2028 9.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021 9.8.1. Hospitals 9.8.2. Ambulatory Surgical Centers 9.8.3. Specialized Dermatology Clinics 9.9. Market Size (US$ Mn) Forecast By End User, 2022-2028 9.10. Drivers and Restraints: Impact Analysis 9.11. Market Attractiveness Analysis 9.11.1. By Country 9.11.2. By Treatment Procedure 9.11.3. By Cellulite 9.11.4. By End User 9.12. Key Market Participants – Intensity Mapping 10. Western Europe Market Analysis 2013-2021 and Forecast 2022-2028 10.1. Introduction 10.2. Historical Market Size (US$ Mn) Analysis By Country, 2013-2021 10.2.1. Germany 10.2.2. U.K 10.2.3. France 10.2.4. Italy 10.2.5. Spain 10.2.6. Rest of Western Europe 10.3. Market Size (US$ Mn) Forecast By Country, 2022-2028 10.3.1. Germany 10.3.2. U.K 10.3.3. France 10.3.4. Italy 10.3.5. Spain 10.3.6. Rest of Western Europe 10.4. Historical Market Size (US$ Mn) Trend Analysis By Treatment Procedure, 2013-2021 10.4.1. Non-Invasive 10.4.2. Minimally Invasive 10.4.3. Topical Treatment 10.5. Market Size (US$ Mn) Forecast By Treatment Procedure, 2022-2028 10.6. Historical Market Size (US$ Mn) Trend Analysis By Cellulite, 2013-2021 10.6.1. Soft Cellulite 10.6.2. Hard Cellulite 10.6.3. Edematous Cellulite 10.7. Market Size (US$ Mn) Forecast By Cellulite, 2022-2028 10.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021 10.8.1. Hospitals 10.8.2. Ambulatory Surgical Centers 10.8.3. Specialized Dermatology Clinics 10.9. Market Size (US$ Mn) Forecast By End User, 2022-2028 10.10. Drivers and Restraints: Impact Analysis 10.11. Market Attractiveness Analysis 10.11.1. By Country 10.11.2. By Treatment Procedure 10.11.3. By Cellulite 10.11.4. By End User 10.12. Key Market Participants – Intensity Mapping 11. Eastern Europe Market Analysis 2013-2021 and Forecast 2022-2028 11.1. Introduction 11.2. Historical Market Size (US$ Mn) Analysis By Country, 2013-2021 11.2.1. Russia 11.2.2. Poland 11.2.3. Rest of Eastern Europe 11.3. Market Size (US$ Mn) Forecast By Country, 2022-2028 11.3.1. Russia 11.3.2. Poland 11.3.3. Rest of Eastern Europe 11.4. Historical Market Size (US$ Mn) Trend Analysis By Treatment Procedure, 2013-2021 11.4.1. Non-Invasive 11.4.2. Minimally Invasive 11.4.3. Topical Treatment 11.5. Market Size (US$ Mn) Forecast By Treatment Procedure, 2022-2028 11.6. Historical Market Size (US$ Mn) Trend Analysis By Cellulite, 2013-2021 11.6.1. Soft Cellulite 11.6.2. Hard Cellulite 11.6.3. Edematous Cellulite 11.7. Market Size (US$ Mn) Forecast By Cellulite, 2022-2028 11.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021 11.8.1. Hospitals 11.8.2. Ambulatory Surgical Centers 11.8.3. Specialized Dermatology Clinics 11.9. Market Size (US$ Mn) Forecast By End User, 2022-2028 11.10. Drivers and Restraints: Impact Analysis 11.11. Market Attractiveness Analysis 11.11.1. By Country 11.11.2. By Treatment Procedure 11.11.3. By Cellulite 11.11.4. By End User 11.12. Key Market Participants – Intensity Mapping 12. Asia Pacific Excluding China & Japan Market Analysis 2013-2021 and Forecast 2022-2028 12.1. Introduction 12.2. Historical Market Size (US$ Mn) Analysis By Country, 2013-2021 12.2.1. India 12.2.2. Australia and New Zealand 12.2.3. ASEAN 12.2.4. Rest of APECJ 12.3. Market Size (US$ Mn) Forecast By Country, 2022-2028 12.3.1. India 12.3.2. Australia and New Zealand 12.3.3. ASEAN 12.3.4. Rest of APECJ 12.4. Historical Market Size (US$ Mn) Trend Analysis By Treatment Procedure, 2013-2021 12.4.1. Non-Invasive 12.4.2. Minimally Invasive 12.4.3. Topical Treatment 12.5. Market Size (US$ Mn) Forecast By Treatment Procedure, 2022-2028 12.6. Historical Market Size (US$ Mn) Trend Analysis By Cellulite, 2013-2021 12.6.1. Soft Cellulite 12.6.2. Hard Cellulite 12.6.3. Edematous Cellulite 12.7. Market Size (US$ Mn) Forecast By Cellulite, 2022-2028 12.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021 12.8.1. Hospitals 12.8.2. Ambulatory Surgical Centers 12.8.3. Specialized Dermatology Clinics 12.9. Market Size (US$ Mn) Forecast By End User, 2022-2028 12.10. Drivers and Restraints: Impact Analysis 12.11. Market Attractiveness Analysis 12.11.1. By Country 12.11.2. By Treatment Procedure 12.11.3. By Cellulite 12.11.4. By End User 12.12. Key Market Participants – Intensity Mapping 13. China Market Analysis 2013-2021 and Forecast 2022-2028 13.1. Introduction 13.2. Historical Market Size (US$ Mn) Trend Analysis By Treatment Procedure, 2013-2021 13.2.1. Non-Invasive 13.2.2. Minimally Invasive 13.2.3. Topical Treatment 13.3. Market Size (US$ Mn) Forecast By Treatment Procedure, 2022-2028 13.4. Historical Market Size (US$ Mn) Trend Analysis By Cellulite, 2013-2021 13.4.1. Soft Cellulite 13.4.2. Hard Cellulite 13.4.3. Edematous Cellulite 13.5. Market Size (US$ Mn) Forecast By Cellulite, 2022-2028 13.6. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021 13.6.1. Hospitals 13.6.2. Ambulatory Surgical Centers 13.6.3. Specialized Dermatology Clinics 13.7. Market Size (US$ Mn) Forecast By End User, 2022-2028 13.8. Drivers and Restraints: Impact Analysis 13.9. Market Attractiveness Analysis 13.9.1. By Treatment Procedure 13.9.2. By Cellulite 13.9.3. By End User 13.10. Key Market Participants – Intensity Mapping 14. Japan Market Analysis 2013-2021 and Forecast 2022-2028 14.1. Introduction 14.2. Historical Market Size (US$ Mn) Trend Analysis By Treatment Procedure, 2013-2021 14.2.1. Non-Invasive 14.2.2. Minimally Invasive 14.2.3. Topical Treatment 14.3. Market Size (US$ Mn) Forecast By Treatment Procedure, 2022-2028 14.4. Historical Market Size (US$ Mn) Trend Analysis By Cellulite, 2013-2021 14.4.1. Soft Cellulite 14.4.2. Hard Cellulite 14.4.3. Edematous Cellulite 14.5. Market Size (US$ Mn) Forecast By Cellulite, 2022-2028 14.6. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021 14.6.1. Hospitals 14.6.2. Ambulatory Surgical Centers 14.6.3. Specialized Dermatology Clinics 14.7. Market Size (US$ Mn) Forecast By End User, 2022-2028 14.8. Drivers and Restraints: Impact Analysis 14.9. Market Attractiveness Analysis 14.9.1. By Treatment Procedure 14.9.2. By Cellulite 14.9.3. By End User 14.10. Key Market Participants – Intensity Mapping 15. Middle East and Africa Market Analysis 2013-2021 and Forecast 2022-2028 15.1. Introduction 15.2. Historical Market Size (US$ Mn) Analysis By Country, 2013-2021 15.2.1. GCC Countries 15.2.2. South Africa 15.2.3. Rest of Middle East and Africa 15.3. Market Size (US$ Mn) Forecast By Country, 2022-2028 15.3.1. GCC Countries 15.3.2. South Africa 15.3.3. Rest of Middle East and Africa 15.4. Historical Market Size (US$ Mn) Trend Analysis By Treatment Procedure, 2013-2021 15.4.1. Non-Invasive 15.4.2. Minimally Invasive 15.4.3. Topical Treatment 15.5. Market Size (US$ Mn) Forecast By Treatment Procedure, 2022-2028 15.6. Historical Market Size (US$ Mn) Trend Analysis By Cellulite, 2013-2021 15.6.1. Soft Cellulite 15.6.2. Hard Cellulite 15.6.3. Edematous Cellulite 15.7. Market Size (US$ Mn) Forecast By Cellulite, 2022-2028 15.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021 15.8.1. Hospitals 15.8.2. Ambulatory Surgical Centers 15.8.3. Specialized Dermatology Clinics 15.9. Market Size (US$ Mn) Forecast By End User, 2022-2028 15.10. Drivers and Restraints: Impact Analysis 15.11. Market Attractiveness Analysis 15.11.1. By Country 15.11.2. By Treatment Procedure 15.11.3. By Cellulite 15.11.4. By End User 15.12. Key Market Participants – Intensity Mapping 16. Forecast Factors: Relevance and Impact 17. Forecast Assumptions 18. Competition Analysis 18.1. Competition Dashboard 18.2. Company Deep Dive 18.2.1. Merz Pharma GmbH & Co. KGaA 18.2.1.1. Overview 18.2.1.2. Product and Application Portfolio 18.2.1.3. Production Footprint 18.2.1.4. Sales Footprint 18.2.1.5. Channel Footprint 18.2.1.6. Strategy 18.2.1.6.1. Marketing Strategy 18.2.1.6.2. Product Strategy 18.2.1.6.3. Channel Strategy 18.2.2. Cynosure, Inc. (Sub. Hologic Inc.) 18.2.2.1. Overview 18.2.2.2. Product and Application Portfolio 18.2.2.3. Production Footprint 18.2.2.4. Sales Footprint 18.2.2.5. Channel Footprint 18.2.2.6. Strategy 18.2.2.6.1. Marketing Strategy 18.2.2.6.2. Product Strategy 18.2.2.6.3. Channel Strategy 18.2.3. Tanceuticals, LLC. 18.2.3.1. Overview 18.2.3.2. Product and Application Portfolio 18.2.3.3. Production Footprint 18.2.3.4. Sales Footprint 18.2.3.5. Channel Footprint 18.2.3.6. Strategy 18.2.3.6.1. Marketing Strategy 18.2.3.6.2. Product Strategy 18.2.3.6.3. Channel Strategy 18.2.4. Inceler Medikal Co. Ltd. 18.2.4.1. Overview 18.2.4.2. Product and Application Portfolio 18.2.4.3. Production Footprint 18.2.4.4. Sales Footprint 18.2.4.5. Channel Footprint 18.2.4.6. Strategy 18.2.4.6.1. Marketing Strategy 18.2.4.6.2. Product Strategy 18.2.4.6.3. Channel Strategy 18.2.5. Cymedics 18.2.5.1. Overview 18.2.5.2. Product and Application Portfolio 18.2.5.3. Production Footprint 18.2.5.4. Sales Footprint 18.2.5.5. Channel Footprint 18.2.5.6. Strategy 18.2.5.6.1. Marketing Strategy 18.2.5.6.2. Product Strategy 18.2.5.6.3. Channel Strategy 18.2.6. Nubway 18.2.6.1. Overview 18.2.6.2. Product and Application Portfolio 18.2.6.3. Production Footprint 18.2.6.4. Sales Footprint 18.2.6.5. Channel Footprint 18.2.6.6. Strategy 18.2.6.6.1. Marketing Strategy 18.2.6.6.2. Product Strategy 18.2.6.6.3. Channel Strategy 18.2.7. Zimmer Aesthetics 18.2.7.1. Overview 18.2.7.2. Product and Application Portfolio 18.2.7.3. Production Footprint 18.2.7.4. Sales Footprint 18.2.7.5. Channel Footprint 18.2.7.6. Strategy 18.2.7.6.1. Marketing Strategy 18.2.7.6.2. Product Strategy 18.2.7.6.3. Channel Strategy 18.2.8. Syneron Medical Inc 18.2.8.1. Overview 18.2.8.2. Product and Application Portfolio 18.2.8.3. Production Footprint 18.2.8.4. Sales Footprint 18.2.8.5. Channel Footprint 18.2.8.6. Strategy 18.2.8.6.1. Marketing Strategy 18.2.8.6.2. Product Strategy 18.2.8.6.3. Channel Strategy 19. Global Market Analysis 2013-2021 and Forecast 2022-2028 By Region 19.1. Introduction / Key Findings 19.2. Historical Market Size (US$ Mn) Analysis By Region 19.2.1. North America 19.2.2. Latin America 19.2.3. Western Europe 19.2.4. Eastern Europe 19.2.5. Asia Pacific Excluding China, Japan 19.2.6. China 19.2.7. Japan 19.2.8. Middle East and Africa 19.3. Market Size (US$ Mn) Forecast By Region 19.3.1. North America 19.3.2. Latin America 19.3.3. Western Europe 19.3.4. Eastern Europe 19.3.5. Asia Pacific Excluding China, Japan 19.3.6. China 19.3.7. Japan 19.3.8. Middle East and Africa 19.4. Market Attractiveness Analysis By Region 20. Global Market Analysis 2013-2021 and Forecast 2022-2028, By Treatment Procedure 20.1. Introduction 20.2. Historical Market Size (US$ Mn) Trend Analysis By Treatment Procedure, 2013-2021 20.2.1. Non-Invasive 20.2.2. Minimally Invasive 20.2.3. Topical Treatment 20.3. Market Size (US$ Mn) Forecast By Treatment Procedure, 2022-2028 20.4. Market Attractiveness Analysis By Treatment Procedure 21. Global Market Analysis 2013-2021 and Forecast 2022-2028, By Cellulite 21.1. Introduction 21.2. Historical Market Size (US$ Mn) Trend Analysis By Cellulite, 2013-2021 21.2.1. Soft Cellulite 21.2.2. Hard Cellulite 21.2.3. Edematous Cellulite 21.3. Market Size (US$ Mn) Forecast By Cellulite, 2022-2028 21.4. Market Attractiveness Analysis By Cellulite 22. Global Market Analysis 2013-2021 and Forecast 2022-2028, By End User 22.1. Introduction 22.2. Historical Market Size (US$ Mn) Trend Analysis By End User, 2013-2021 22.2.1. Hospitals 22.2.2. Ambulatory Surgical Centers 22.2.3. Specialized Dermatology Clinics 22.3. Market Size (US$ Mn) Forecast By End User, 2022-2028 22.4. Market Attractiveness Analysis By End User 23. Global Market Analysis 2013-2021 and Forecast 2022-2028 23.1. Y-o-Y Growth Analysis By All Segment 23.2. Absolute $ Opportunity 24. Assumptions and Acronyms Used 25. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 01 : North Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Country Table 02 : North America Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Treatment Procedure Table 03 : North America Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Cellulite Table 04 : North America Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By End User Table 05 : Latin America Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Country Table 06 : Latin America Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Treatment Procedure Table 07 : Latin America Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Cellulite Table 08 : Latin America Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By End User Table 09 : Western Europe Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Country Table 10 : Western Europe Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Treatment Procedure Table 11 : Western Europe Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Cellulite Table 12 : Western Europe Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By End User Table 13 : Eastern Europe Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Country Table 14 : Eastern Europe Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Treatment Procedure Table 15 : Eastern Europe Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Cellulite Table 16 : Eastern Europe Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By End User Table 17 : APEJC Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Country Table 18 : APEJC Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Treatment Procedure Table 19 : APEJC Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Cellulite Table 20 : APEJC Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By End User Table 21 : China Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Treatment Procedure Table 22 : China Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Cellulite Table 23 : China Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By End User Table 24 : Japan Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Treatment Procedure Table 25 : Japan Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Cellulite Table 26 : Japan Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By End User Table 27 : MEA Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Country Table 28 : MEA Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Treatment Procedure Table 29 : MEA Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Cellulite Table 30 : MEA Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By End User Table 31 : Global Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Region Table 32 : Global Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Treatment Procedure Table 33 : Global Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By Cellulite Table 34 : Global Market Size (US$ Mn) Analysis 2013-2021 and Forecast 2022-2028, By End User
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 01 : Global Market Value Share By Treatment Procedure (2022 E) Figure 02 : Global Market Value Share By Cellulite (2022 E) Figure 03 : Global Market Value Share By End User (2022 E) Figure 04 : Global Market Value Share By Region (2022 E) Figure 05 : Global Healthcare Expenditure in US$ Tn (2013–2020) Figure 06 : Therapeutic Area Figure 07 : North America Market Share, By Treatment Procedure (2022) Figure 08 : North America Market Share, By Cellulite (2022) Figure 09 : North America Market Share, By End User (2022) Figure 10 : North America Market Share, By Country (2022) Figure 11 : North America Market size (US$ Mn) 2022 & 2028 Figure 12 : North America Market Size (US$ Mn) Analysis, 2013-2021 Figure 13 : North America Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028 Figure 14 : North America Market Size (US$ Mn) Analysis, 2013-2021, By Non-Invasive Figure 15 : North America Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Non-Invasive Figure 16 : North America Market Size (US$ Mn) Analysis, 2013-2021, By Minimally Invasive Figure 17 : North America Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Minimally Invasive Figure 18 : North America Market Size (US$ Mn) Analysis, 2013-2021, By Topical Treatment Figure 19 : North America Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Topical Treatment Figure 20 : North America Market Size (US$ Mn) Analysis, 2013-2021, By Soft Cellulite Figure 21 : North America Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Soft Cellulite Figure 22 : North America Market Size (US$ Mn) Analysis, 2013-2021, By Hard Cellulite Figure 23 : North America Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Hard Cellulite Figure 24 : North America Market Size (US$ Mn) Analysis, 2013-2021, By Edematous Cellulite Figure 25 : North America Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Edematous Cellulite Figure 26 : North America Market Size (US$ Mn) Analysis, 2013-2021, By Hospitals Figure 27 : North America Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Hospitals Figure 28 : North America Market Size (US$ Mn) Analysis, 2013-2021, By Ambulatory Surgical Centers Figure 29 : North America Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Ambulatory Surgical Centers Figure 30 : North America Market Size (US$ Mn) Analysis, 2013-2021, By Specialized Dermatology Clinics Figure 31 : North America Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Specialized Dermatology Clinics Figure 32 : North America Market Attractiveness Analysis, , By Country Figure 33 : North America Market Attractiveness Analysis, By Treatment Procedure Figure 34 : North America Market Attractiveness Analysis, By Cellulite Figure 35 : North America Market Attractiveness Analysis, By End User Figure 36 : Latin America Market Share, By Treatment Procedure (2022) Figure 37 : Latin America Market Share, By Cellulite (2022) Figure 38 : Latin America Market Share, By End User (2022) Figure 39 : Latin America Market Share, By Country (2022) Figure 40 : Latin America Market size (US$ Mn) 2022 & 2028 Figure 41 : Latin America Market Size (US$ Mn) Analysis, 2013-2021 Figure 42 : Latin America Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028 Figure 43 : Latin America Market Size (US$ Mn) Analysis, 2013-2021, By Non-Invasive Figure 44 : Latin America Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Non-Invasive Figure 45 : Latin America Market Size (US$ Mn) Analysis, 2013-2021, By Minimally Invasive Figure 46 : Latin America Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Minimally Invasive Figure 47 : Latin America Market Size (US$ Mn) Analysis, 2013-2021, By Topical Treatment Figure 48 : Latin America Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Topical Treatment Figure 49 : Latin America Market Size (US$ Mn) Analysis, 2013-2021, By Soft Cellulite Figure 50 : Latin America Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Soft Cellulite Figure 51 : Latin America Market Size (US$ Mn) Analysis, 2013-2021, By Hard Cellulite Figure 52 : Latin America Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Hard Cellulite Figure 53 : Latin America Market Size (US$ Mn) Analysis, 2013-2021, By Edematous Cellulite Figure 54 : Latin America Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Edematous Cellulite Figure 55 : Latin America Market Size (US$ Mn) Analysis, 2013-2021, By Hospitals Figure 56 : Latin America Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Hospitals Figure 57 : Latin America Market Size (US$ Mn) Analysis, 2013-2021, By Ambulatory Surgical Centers Figure 58 : Latin America Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Ambulatory Surgical Centers Figure 59 : Latin America Market Size (US$ Mn) Analysis, 2013-2021, By Specialized Dermatology Clinics Figure 60 : Latin America Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Specialized Dermatology Clinics Figure 61 : Latin America Market Attractiveness Analysis, , By Country Figure 62 : Latin America Market Attractiveness Analysis, By Treatment Procedure Figure 63 : Latin America Market Attractiveness Analysis, By Cellulite Figure 64 : Latin America Market Attractiveness Analysis, By End User Figure 65 : Western Europe Market Share, By Treatment Procedure (2022) Figure 66 : Western Europe Market Share, By Cellulite (2022) Figure 67 : Western Europe Market Share, By End User (2022) Figure 68 : Western Europe Market Share, By Country (2022) Figure 69 : Western Europe Market size (US$ Mn) 2022 & 2028 Figure 70 : Western Europe Market Size (US$ Mn) Analysis, 2013-2021 Figure 71 : Western Europe Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028 Figure 72 : Western Europe Market Size (US$ Mn) Analysis, 2013-2021, By Non-Invasive Figure 73 : Western Europe Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Non-Invasive Figure 74 : Western Europe Market Size (US$ Mn) Analysis, 2013-2021, By Minimally Invasive Figure 75 : Western Europe Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Minimally Invasive Figure 76 : Western Europe Market Size (US$ Mn) Analysis, 2013-2021, By Topical Treatment Figure 77 : Western Europe Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Topical Treatment Figure 78 : Western Europe Market Size (US$ Mn) Analysis, 2013-2021, By Soft Cellulite Figure 79 : Western Europe Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Soft Cellulite Figure 80 : Western Europe Market Size (US$ Mn) Analysis, 2013-2021, By Hard Cellulite Figure 81 : Western Europe Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Hard Cellulite Figure 82 : Western Europe Market Size (US$ Mn) Analysis, 2013-2021, By Edematous Cellulite Figure 83 : Western Europe Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Edematous Cellulite Figure 84 : Western Europe Market Size (US$ Mn) Analysis, 2013-2021, By Hospitals Figure 85 : Western Europe Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Hospitals Figure 86 : Western Europe Market Size (US$ Mn) Analysis, 2013-2021, By Ambulatory Surgical Centers Figure 87 : Western Europe Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Ambulatory Surgical Centers Figure 88 : Western Europe Market Size (US$ Mn) Analysis, 2013-2021, By Specialized Dermatology Clinics Figure 89: Western Europe Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Specialized Dermatology Clinics Figure 90 : Western Europe Market Attractiveness Analysis, , By Country Figure 91 : Western Europe Market Attractiveness Analysis, By Treatment Procedure Figure 92 : Western Europe Market Attractiveness Analysis, By Cellulite Figure 93 : Western Europe Market Attractiveness Analysis, By End User Figure 94 : Eastern Europe Market Share, By Treatment Procedure (2022) Figure 95 : Eastern Europe Market Share, By Cellulite (2022) Figure 96 : Eastern Europe Market Share, By End User (2022) Figure 97 : Eastern Europe Market Share, By Country (2022) Figure 98 : Eastern Europe Market size (US$ Mn) 2022 & 2028 Figure 99 : Eastern Europe Market Size (US$ Mn) Analysis, 2013-2021 Figure 100 : Eastern Europe Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028 Figure 101 : Eastern Europe Market Size (US$ Mn) Analysis, 2013-2021, By Non-Invasive Figure 102 : Eastern Europe Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Non-Invasive Figure 103 : Eastern Europe Market Size (US$ Mn) Analysis, 2013-2021, By Minimally Invasive Figure 104 : Eastern Europe Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Minimally Invasive Figure 105 : Eastern Europe Market Size (US$ Mn) Analysis, 2013-2021, By Topical Treatment Figure 106 : Eastern Europe Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Topical Treatment Figure 107 : Eastern Europe Market Size (US$ Mn) Analysis, 2013-2021, By Soft Cellulite Figure 108 : Eastern Europe Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Soft Cellulite Figure 109 : Eastern Europe Market Size (US$ Mn) Analysis, 2013-2021, By Hard Cellulite Figure 110 : Eastern Europe Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Hard Cellulite Figure 111 : Eastern Europe Market Size (US$ Mn) Analysis, 2013-2021, By Edematous Cellulite Figure 112 : Eastern Europe Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Edematous Cellulite Figure 113 : Eastern Europe Market Size (US$ Mn) Analysis, 2013-2021, By Hospitals Figure 114 : Eastern Europe Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Hospitals Figure 115 : Eastern Europe Market Size (US$ Mn) Analysis, 2013-2021, By Ambulatory Surgical Centers Figure 116 : Eastern Europe Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Ambulatory Surgical Centers Figure 117 : Eastern Europe Market Size (US$ Mn) Analysis, 2013-2021, By Specialized Dermatology Clinics Figure 118 : Eastern Europe Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Specialized Dermatology Clinics Figure 119 : Eastern Europe Market Attractiveness Analysis, , By Country Figure 120 : Eastern Europe Market Attractiveness Analysis, By Treatment Procedure Figure 121 : Eastern Europe Market Attractiveness Analysis, By Cellulite Figure 122 : Eastern Europe Market Attractiveness Analysis, By End User Figure 123 : APEJC Market Share, By Treatment Procedure (2022) Figure 124 : APEJC Market Share, By Cellulite (2022) Figure 125 : APEJC Market Share, By End User (2022) Figure 126 : APEJC Market Share, By Country (2022) Figure 127 : APEJC Market size (US$ Mn) 2022 & 2028 Figure 128 : APEJC Market Size (US$ Mn) Analysis, 2013-2021 Figure 129 : APEJC Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028 Figure 130 : APEJC Market Size (US$ Mn) Analysis, 2013-2021, By Non-Invasive Figure 131 : APEJC Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Non-Invasive Figure 132 : APEJC Market Size (US$ Mn) Analysis, 2013-2021, By Minimally Invasive Figure 133 : APEJC Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Minimally Invasive Figure 134 : APEJC Market Size (US$ Mn) Analysis, 2013-2021, By Topical Treatment Figure 135 : APEJC Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Topical Treatment Figure 136 : APEJC Market Size (US$ Mn) Analysis, 2013-2021, By Soft Cellulite Figure 137 : APEJC Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Soft Cellulite Figure 138 : APEJC Market Size (US$ Mn) Analysis, 2013-2021, By Hard Cellulite Figure 139 : APEJC Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Hard Cellulite Figure 140 : APEJC Market Size (US$ Mn) Analysis, 2013-2021, By Edematous Cellulite Figure 141 : APEJC Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Edematous Cellulite Figure 142 : APEJC Market Size (US$ Mn) Analysis, 2013-2021, By Hospitals Figure 143 : APEJC Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Hospitals Figure 144 : APEJC Market Size (US$ Mn) Analysis, 2013-2021, By Ambulatory Surgical Centers Figure 145 : APEJC Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Ambulatory Surgical Centers Figure 146 : APEJC Market Size (US$ Mn) Analysis, 2013-2021, By Specialized Dermatology Clinics Figure 147 : APEJC Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Specialized Dermatology Clinics Figure 148 : APEJC Market Attractiveness Analysis, , By Country Figure 149 : APEJC Market Attractiveness Analysis, By Treatment Procedure Figure 150 : APEJC Market Attractiveness Analysis, By Cellulite Figure 151 : APEJC Market Attractiveness Analysis, By End User Figure 152 : China Market Share, By Treatment Procedure (2022) Figure 153 : China Market Share, By Cellulite (2022) Figure 154 : China Market Share, By End User (2022) Figure 155 : China Market size (US$ Mn) 2022 & 2028 Figure 156 : China Market Size (US$ Mn) Analysis, 2013-2021 Figure 157 : China Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028 Figure 158 : China Market Size (US$ Mn) Analysis, 2013-2021, By Non-Invasive Figure 159 : China Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Non-Invasive Figure 160 : China Market Size (US$ Mn) Analysis, 2013-2021, By Minimally Invasive Figure 161 : China Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Minimally Invasive Figure 162 : China Market Size (US$ Mn) Analysis, 2013-2021, By Topical Treatment Figure 163 : China Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Topical Treatment Figure 164 : China Market Size (US$ Mn) Analysis, 2013-2021, By Soft Cellulite Figure 165 : China Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Soft Cellulite Figure 166 : China Market Size (US$ Mn) Analysis, 2013-2021, By Hard Cellulite Figure 167 : China Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Hard Cellulite Figure 168 : China Market Size (US$ Mn) Analysis, 2013-2021, By Edematous Cellulite Figure 169 : China Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Edematous Cellulite Figure 170 : China Market Size (US$ Mn) Analysis, 2013-2021, By Hospitals Figure 171 : China Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Hospitals Figure 172 : China Market Size (US$ Mn) Analysis, 2013-2021, By Ambulatory Surgical Centers Figure 173 : China Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Ambulatory Surgical Centers Figure 174 : China Market Size (US$ Mn) Analysis, 2013-2021, By Specialized Dermatology Clinics Figure 175 : China Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Specialized Dermatology Clinics Figure 176 : China Market Attractiveness Analysis, By Treatment Procedure Figure 177 : China Market Attractiveness Analysis, By Cellulite Figure 178 : China Market Attractiveness Analysis, By End User Figure 179 : Japan Market Share, By Treatment Procedure (2022) Figure 180 : Japan Market Share, By End User (2022) Figure 181 : Japan Market Share, By Cellulite (2022) Figure 182 : Japan Market size (US$ Mn) 2022 & 2028 Figure 183 : Japan Market Size (US$ Mn) Analysis, 2013-2021 Figure 184 : Japan Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028 Figure 185 : Japan Market Size (US$ Mn) Analysis, 2013-2021, By Non-Invasive Figure 186 : Japan Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Non-Invasive Figure 187 : Japan Market Size (US$ Mn) Analysis, 2013-2021, By Minimally Invasive Figure 188 : Japan Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Minimally Invasive Figure 189 : Japan Market Size (US$ Mn) Analysis, 2013-2021, By Topical Treatment Figure 190 : Japan Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Topical Treatment Figure 191 : Japan Market Size (US$ Mn) Analysis, 2013-2021, By Soft Cellulite Figure 192 : Japan Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Soft Cellulite Figure 193 : Japan Market Size (US$ Mn) Analysis, 2013-2021, By Hard Cellulite Figure 194 : Japan Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Hard Cellulite Figure 195 : Japan Market Size (US$ Mn) Analysis, 2013-2021, By Edematous Cellulite Figure 196 : Japan Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Edematous Cellulite Figure 197 : Japan Market Size (US$ Mn) Analysis, 2013-2021, By Hospitals Figure 198 : Japan Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Hospitals Figure 199 : Japan Market Size (US$ Mn) Analysis, 2013-2021, By Ambulatory Surgical Centers Figure 200 : Japan Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Ambulatory Surgical Centers Figure 201 : Japan Market Size (US$ Mn) Analysis, 2013-2021, By Specialized Dermatology Clinics Figure 202 : Japan Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Specialized Dermatology Clinics Figure 203 : Japan Market Attractiveness Analysis, By Treatment Procedure Figure 204 : Japan Market Attractiveness Analysis, By Cellulite Figure 205 : Japan Market Attractiveness Analysis, By End User Figure 206 : MEA Market Share, By Treatment Procedure (2022) Figure 207 : MEA Market Share, By Cellulite (2022) Figure 208 : MEA Market Share, By End User (2022) Figure 209 : MEA Market Share, By Country (2022) Figure 210 : MEA Market size (US$ Mn) 2022 & 2028 Figure 211 : MEA Market Size (US$ Mn) Analysis, 2013-2021 Figure 212 : MEA Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028 Figure 213 : MEA Market Size (US$ Mn) Analysis, 2013-2021, By Non-Invasive Figure 214 : MEA Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Non-Invasive Figure 215 : MEA Market Size (US$ Mn) Analysis, 2013-2021, By Minimally Invasive Figure 216 : MEA Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Minimally Invasive Figure 217 : MEA Market Size (US$ Mn) Analysis, 2013-2021, By Topical Treatment Figure 218 : MEA Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Topical Treatment Figure 219 : MEA Market Size (US$ Mn) Analysis, 2013-2021, By Soft Cellulite Figure 220 : MEA Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Soft Cellulite Figure 221 : MEA Market Size (US$ Mn) Analysis, 2013-2021, By Hard Cellulite Figure 222 : MEA Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Hard Cellulite Figure 223 : MEA Market Size (US$ Mn) Analysis, 2013-2021, By Edematous Cellulite Figure 224 : MEA Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Edematous Cellulite Figure 225 : MEA Market Size (US$ Mn) Analysis, 2013-2021, By Hospitals Figure 226 : MEA Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Hospitals Figure 227 : MEA Market Size (US$ Mn) Analysis, 2013-2021, By Ambulatory Surgical Centers Figure 228 : MEA Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Ambulatory Surgical Centers Figure 229 : MEA Market Size (US$ Mn) Analysis, 2013-2021, By Specialized Dermatology Clinics Figure 230 : MEA Market Size (US$ Mn) & Y-o-Y Growth (%), 2022-2028, By Specialized Dermatology Clinics Figure 231 : MEA Market Attractiveness Analysis, , By Country Figure 232 : MEA Market Attractiveness Analysis, By Treatment Procedure Figure 233 : MEA Market Attractiveness Analysis, By Cellulite Figure 234 : MEA Market Attractiveness Analysis, By End User Figure 235 : Global Market Attractiveness Analysis, By Region Figure 236 : Global Market Attractiveness Analysis, By Treatment Procedure Figure 237 : Global Market Attractiveness Analysis, By Cellulite Figure 238 : Global Market Attractiveness Analysis, By End User Figure 239 : Global Single-Photon Emission Computed Tomography Historical Market Size and Y-o-Y, 2013- 2022 Figure 240 : Global Market Size (US$ Mn) & Y-o-Y Growth (%), 2022–2028 Figure 241 : Global Market Absolute $ Opportunity, 2013 – 2028
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
